FREE Daily Stock Alerts From Stock-PR.com
Power3 Medical Products, Inc. (OTC:PWRM)
PWRM, a bio-technology company, engages in the development and marketing of diagnostic tests in the fields of cancer, and neurodegenerative and neuromuscular diseases in the United States. PWRM’s products include BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer; and NuroPro, a serum test for the detection of neurodegenerative diseases, such as amyotrophic lateral sclerosis, Alzheimer’s disease, and Parkinson’s disease. PWRM’s products analyze proteins and their mutations to assess an individual’s risk for developing disease later in life or a patient’s likelihood of responding to a particular drug; assess a patient’s risk of disease progression and disease recurrence; and measure a patient’s exposure to drug therapy. PWRM was formerly known as Surgical Safety Products, Inc. and changed its name to Power3 Medical Products, Inc. in September 2003. PWRM was founded in 1992 and is based in The Woodlands, Texas.
PWRM, a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced earlier this month that it delivered four poster presentations at the 2010 International Conference on Alzheimer’s Disease (NASDAQ:ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro, PWRM’s diagnostic test, and focused on PWRM’s Alzheimer’s disease blood serum biomarkers, test and clinical validation trials.
PWRM has filed several patent applications for its NuroPro technology that are currently pending. PWRM also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, PWRM has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China, and has published 6 articles in peer-reviewed scientific journals on the subject. PWRM intends to publish these latest findings as well.
To learn more about PWRM visit: http://www.Power3Medical.com
G&K Services, Inc. (NASDAQ:GKSR)
GKSR, will report fiscal 2011 first quarter results on Tuesday, November 2, 2010 before the market opens. GKSR will also host a conference call to discuss financial results. A live webcast of the call will be available beginning at 10 a.m., Central Time, on November 2, 2010.
To access the live webcast, go to the Investor Relations section of GKSR’s website at www.gkservices.com. Click on the webcast icon and follow the instructions. For those unable to listen to the live webcast, a replay of the call will be available on GKSR’s website through December 2, 2010.
The Gabelli Convertible and Income Securities Fund Inc. (NYSE:GCV)
The Board of Directors of GCV reaffirmed its 8% distribution policy and declared an $0.11 per share cash distribution which was paid on September 23, 2010 to common stock shareholders of record on September 16, 2010.
GCV intends to pay a quarterly distribution of an amount determined each quarter by the Board of Directors. Under GCV’s current distribution policy, the Fund intends to pay a minimum annual distribution of 8% of the average net asset value of GCV within a calendar year or an amount sufficient to satisfy the minimum distribution requirements of the Internal Revenue Code, whichever is greater. The average net asset value of GCV is based on the average net asset values as of the last day of the four preceding calendar quarters during the year. We note that 8% of the average net asset value of GCV would be $0.47 based on the ending net asset values per share as of December 31, 2009, March 31, 2010, and June 30, 2010 of $5.94, $6.09, and $5.59, respectively. The net asset value per share fluctuates daily.
GAMCO Investors, Inc. (NYSE:GBL)
GBL recently named Robert D. Leininger, CFA as Portfolio Manager of the Gabelli Dividend and Income Trust Inc. (NYSE:GDV), GBL’s largest closed-end fund with $1.7 billion in assets, launched on November 28, 2003. Mr. Leininger joins Mario J. Gabelli and Barbara G. Marcin who have been the team portfolio managers of the Gabelli Dividend and Income Trust since its inception.
“Bob has an excellent foundation in Graham & Dodd fundamental research that he developed early in his career,” Mr. Gabelli said. “This experience coupled with the dozen years he managed income-oriented, value portfolios will serve the Trust well.”
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (OTC:PWRM).
Sign Up For Free Stock Alerts At http://stock-pr.com/signup
________________________________________Be Sure To Visit stock-pr.ning.com
The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.